In light of J&J news, of primary concern with regard to vaccine confidence in the US is the 15-20% of adults still on the fence about getting vaccinated. Could the pause, and the messaging around it, change minds from "wait and see" to "no thanks"?
kff.org/coronavirus-co…
kff.org/coronavirus-co…
The most common concerns about vaccines in the "wait and see" group revolve around safety and side effects, so if a perception takes hold - for whatever reason - that a vaccine is "unsafe" it could have implications for willingness to be vaccinated especially in this group.
Can't predict how things will play out here, but concerning precedent that several European countries saw a decline in confidence in the AstraZeneca vaccine after a week-long pause initiated for similar reasons as we're seeing for J&J
dw.com/en/european-tr…
dw.com/en/european-tr…
It's also unclear how changing perceptions about J&J might impact people's views of the other two vaccines here. Most people in the US say they aren't sure if there are differences between the how the three authorized vaccines work
And, among those who are in the "Wait and see" group, there was a preference, prior to the news of the pause, for J&J, unclear how these views change in light of J&J news.
All of which would indicate the importance of ensuring clear and trustworthy communication about the pause, the findings, implications. (as is always the case!)
• • •
Missing some Tweet in this thread? You can try to
force a refresh
